Get the app!
Back to Trades
Sell4

MADRIGAL PHARMACEUTICALS, INC.

MDGL

Total Value
$10.2M
Net $9.6M sold
Sales
$9.6M
28 transactions

Company Information

Ticker Symbol
MDGL
CIK
0001157601

Insider Information

Role
Director
Director
Location
WEST CONSHOHOCKEN, PA

Filing Details

Filing Date
Jan 13, 2026
Transaction Date
Jan 9, 2026
Accession Number
0001628280-26-001961
Form Type
4
Net Trading Amount
-$9.6M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jan 9, 2026Common Stock18,410$15.80Exercise$290.9K
Jan 9, 2026Common Stock960$512.02Sale$491.5K
Jan 9, 2026Common Stock960$513.12Sale$492.6K
Jan 9, 2026Common Stock937$514.63Sale$482.2K
Jan 9, 2026Common Stock1,578$515.82Sale$814.0K
Jan 9, 2026Common Stock521$516.81Sale$269.3K
Jan 9, 2026Common Stock2,044$517.84Sale$1.1M
Jan 9, 2026Common Stock970$518.67Sale$503.1K
Jan 9, 2026Common Stock539$519.89Sale$280.2K
Jan 9, 2026Common Stock440$521.11Sale$229.3K
Jan 9, 2026Common Stock588$521.95Sale$306.9K
Jan 9, 2026Common Stock732$522.98Sale$382.8K
Jan 9, 2026Common Stock1,335$524.06Sale$699.6K
Jan 9, 2026Common Stock1,489$525.12Sale$781.9K
Jan 9, 2026Common Stock913$526.05Sale$480.3K
Jan 9, 2026Common Stock1,135$526.95Sale$598.1K
Jan 9, 2026Common Stock465$528.16Sale$245.6K
Jan 9, 2026Common Stock554$529.28Sale$293.2K
Jan 9, 2026Common Stock256$530.45Sale$135.8K
Jan 9, 2026Common Stock30$531.05Sale$15.9K
Jan 9, 2026Common Stock40$532.50Sale$21.3K
Jan 9, 2026Common Stock271$534.18Sale$144.8K
Jan 9, 2026Common Stock89$534.93Sale$47.6K
Jan 9, 2026Common Stock299$535.80Sale$160.2K
Jan 9, 2026Common Stock385$536.88Sale$206.7K
Jan 9, 2026Common Stock40$537.84Sale$21.5K
Jan 9, 2026Common Stock400$539.26Sale$215.7K
Jan 9, 2026Common Stock40$540.26Sale$21.6K
Jan 9, 2026Common Stock400$542.72Sale$217.1K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Jan 9, 2026Derivative18,410$15.80Exercise$290.9K

Footnotes

  1. (F1)These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
  2. (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.71 to $512.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
  3. (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $513.00 to $513.58, inclusive.
  4. (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.32 to $515.25, inclusive.
  5. (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.32 to $516.29, inclusive.
  6. (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.32 to $517.26, inclusive.
  7. (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.36 to $518.35, inclusive.
  8. (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.39 to $519.29, inclusive.
  9. (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.45 to $520.38, inclusive.
  10. (F10)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.46 to $521.45, inclusive.
  11. (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.50 to $522.49, inclusive.
  12. (F12)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.51 to $523.47, inclusive.
  13. (F13)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.59 to $524.58, inclusive.
  14. (F14)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.59 to $525.56, inclusive.
  15. (F15)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.59 to $526.55, inclusive.
  16. (F16)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.63 to $527.58, inclusive.
  17. (F17)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.71 to $528.52, inclusive.
  18. (F18)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.72 to $529.69, inclusive.
  19. (F19)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.97 to $530.63, inclusive.
  20. (F20)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.60 to $534.57, inclusive.
  21. (F21)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.60 to $534.99, inclusive.
  22. (F22)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.62 to $536.32, inclusive.
  23. (F23)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.30, inclusive.
  24. (F24)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.00 to $539.44, inclusive.
  25. (F25)The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  26. (F26)The shares underlying this stock option are fully vested and exercisable.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.